Dobutamine Inotropic Support

Searching for Dobutamine Inotropic Support information? Find all needed info by using official links provided below.


Use of Inotropic Agents in Treatment of Systolic Heart Failure

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691094/
    Dec 04, 2015 · Long-term inotropic therapy should be offered in selected patients. A detailed conversation with the patient and family shall be held, including a discussion on the risks and benefits of use of inotropes. Chronic heart failure patients awaiting heart transplants are candidates for intravenous inotropic support until the donor heart becomes ...Cited by: 30

Inotropic agents, inotropic drugs, inotropic medications

    https://healthjade.net/inotropic/
    Dobutamine, the most commonly used inotropic agent worldwide, is a non-selective β1- and β2-adrenergic receptor agonist with variable activities on the α1 receptor 9). Prevalent β1- and β2-adrenergic receptor activation results in reduced afterload and increased stroke volume, heart rate and cardiac output at low doses.

UpToDate

    https://www.uptodate.com/contents/inotropic-agents-in-heart-failure-with-reduced-ejection-fraction
    May 25, 2018 · Those with HF with preserved ejection fraction (HFpEF; also known as diastolic HF) do not need inotropic support, and the myocardial effects of these agents may be detrimental in such patients. The efficacy of acute intravenous inotropic support is well established in patients with severe myocardial systolic dysfunction.

Dobutamine - FDA prescribing information, side effects and ...

    https://www.drugs.com/pro/dobutamine.html
    Jun 29, 2005 · Dobutamine Injection, USP is indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of adults with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures.

Inotropes and Vasopressors Circulation

    https://www.ahajournals.org/doi/abs/10.1161/circulationaha.107.728840
    The pharmacology of dobutamine. Am J Med Sci. 1987; 294 ... Inotropic therapy for heart failure: an evidence-based approach. Am Heart J. 2001 ... Walker TL, Dutton D, Burgess D. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail ...Cited by: 323

DOBUTAMINE Drug BNF content published by NICE

    https://bnf.nice.org.uk/drug/dobutamine.html
    Dobutamine is a cardiac stimulant which acts on beta 1 receptors in cardiac muscle, and increases contractility. Indications and dose Inotropic support in infarction, cardiac surgery, cardiomyopathies, septic shock, cardiogenic shock, and during positive end expiratory pressure ventilation

List of Inotropic agents - Drugs.com

    https://www.drugs.com/drug-class/inotropic-agents.html
    Inotropic agents are a group of medicines that affect the contraction of the heart muscle. Technically, inotropes can be divided into positive inotropes, which stimulate and increase the force of contraction of the heart muscle, and negative inotropes, which weaken the force of muscular contractions, decreasing how hard the heart has to work.



How to find Dobutamine Inotropic Support information?

Follow the instuctions below:

  • Choose an official link provided above.
  • Click on it.
  • Find company email address & contact them via email
  • Find company phone & make a call.
  • Find company address & visit their office.

Related Companies Support